» Articles » PMID: 29190934

Red Blood Cell Distribution Width As a Predictor of Survival in Nasal-type, Extranodal Natural Killer/T-cell Lymphoma

Overview
Journal Oncotarget
Specialty Oncology
Date 2017 Dec 2
PMID 29190934
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

We retrospectively enrolled 191 nasal-type, extranodal natural killer/T-cell lymphoma (ENKTL) patients newly diagnosed from 2008 to 2016 at the Sichuan Cancer Hospital, in order to evaluate the relationship between disease outcomes, demographic and clinical factors, and red blood cell distribution width (RDW). C-index, fisher's exact test, univariate analysis, and cox regression analysis were applied. The median age of patients was 44 years and 134 (70%) were men. The cutoff of RDW was 46.2 fL determined by Cutoff Finder. Patients with RDW≤46.2 fL had significantly better progression-free survival (PFS) (3-year PFS, 80.4% vs. 63.1%; =0.01) and overall survival (OS) (3-year OS, 83.2% vs. 65.5%; =0.004) than those with RDW>46.2 fL. Multivariate analysis demonstrated that elevated RDW is an independent adverse predictor of OS (=0.021, HR=2.04). RDW is an independent predictor of survival outcomes in ENKTL, which we found to be superior to both the prognostic index of natural killer lymphoma (PINK) and the Korean Prognostic Index (KPI) in discriminating patients with different outcomes in low-risk and high-risk groups (all < 0.05). The new models combining RDW with the International Prognostic Index (IPI), KPI, and PINK showed more powerful prognostic value than corresponding original models. RDW represents an easily available and inexpensive marker for risk stratification in patients with ENKTL treated with radiotherapy-based treatment. Further prospective studies are warranted to confirm the prognostic value of RDW in ENKTL.

Citing Articles

The elevation of red blood cell distribution width is an independent prognostic factor for juvenile myelomonocytic leukemia.

Liang W, Liu C, Zhang J, Yi M, Cai Y, Zhang A Blood Sci. 2024; 6(2):e00186.

PMID: 38681968 PMC: 11049728. DOI: 10.1097/BS9.0000000000000186.


Usefulness of baseline immature reticulocyte fraction to mature reticulocyte fraction ratio (IMR) as A prognostic predictor for patients with small cell lung cancer.

Zhang X, Ren H, Tian J, Yang C, Luo H Heliyon. 2024; 10(1):e23830.

PMID: 38192754 PMC: 10772623. DOI: 10.1016/j.heliyon.2023.e23830.


Prognostic value of red blood cell distribution width and D-Dimer in diffuse large B-cell lymphoma: Systematic review and meta-analysis.

Rahchamani M, Sedghi M, Hakimi A, Nejatianfar M, Javaheri T, Tavakoli R Cancer Rep (Hoboken). 2023; 7(1):e1936.

PMID: 37997648 PMC: 10809198. DOI: 10.1002/cnr2.1936.


Molecular Mechanism Exploration of Autologous Blood Transfusion with RBC Surface Membrane Protein pMHC/aCD28 Combined with CD8+T Cells to Promote the Proliferation of CD8+T Cells to Inhibit the Malignant Transformation of Liver Cancer.

Tao H, Liu T, Yao N, Wang J, Xu J, Zhou X J Oncol. 2022; 2022:6102672.

PMID: 36213824 PMC: 9534649. DOI: 10.1155/2022/6102672.


Towards Next Generation Biomarkers in Natural Killer/T-Cell Lymphoma.

Chan J, Lim J, Ong C Life (Basel). 2021; 11(8).

PMID: 34440582 PMC: 8398475. DOI: 10.3390/life11080838.


References
1.
. A predictive model for aggressive non-Hodgkin's lymphoma. N Engl J Med. 1993; 329(14):987-94. DOI: 10.1056/NEJM199309303291402. View

2.
Wang L, Xia Z, Huang H, Lu Y, Zhang Y . Cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) in the treatment of stage IE/IIE extranodal natural killer/T cell lymphoma, nasal type: 13-year follow-up in 135 patients. Int J Hematol. 2012; 96(5):617-23. DOI: 10.1007/s12185-012-1174-y. View

3.
Chim C, Ma S, Au W, Choy C, Lie A, Liang R . Primary nasal natural killer cell lymphoma: long-term treatment outcome and relationship with the International Prognostic Index. Blood. 2003; 103(1):216-21. DOI: 10.1182/blood-2003-05-1401. View

4.
Cheson B, Horning S, Coiffier B, Shipp M, Fisher R, Connors J . Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol. 1999; 17(4):1244. DOI: 10.1200/JCO.1999.17.4.1244. View

5.
Sun P, Zhang F, Chen C, Bi X, Yang H, An X . The ratio of hemoglobin to red cell distribution width as a novel prognostic parameter in esophageal squamous cell carcinoma: a retrospective study from southern China. Oncotarget. 2016; 7(27):42650-42660. PMC: 5173164. DOI: 10.18632/oncotarget.9516. View